Regeneron Pharma (REGN) PT Raised to $895 at Piper Sandler
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $783.56 -1.22%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Join SI Premium – FREE
Piper Sandler analyst Christopher Raymond raised the price target on Regeneron Pharma (NASDAQ: REGN) to $895.00 (from $885.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Clear Secure Inc (YOU) PT Lowered to $45 at DA Davidson
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
